Peptide Libraray

Sequence 31 from Patent US 20110319336

General Information

DCTPep ID DCTPep01396

Peptide Name Sequence 31 from Patent US 20110319336

Sequence WHSDMEWWYLLG

Sequence Length 12

UniProt ID Not available

PubChem CID Not available

Origin Synthetic construct

Type Synthetic peptide

Classification

ACP

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Not available

Disulfide/Other Bond Not available

N-terminal Modification Not available

C-terminal Modification CONH2 is existing at C-terminal

Other Modification None

Chiral L

Physicochemical Information

Formula C79H99N17O19S1

Absent amino acids ACFIKNPQRTV

Theoretical pI 4.35

Acidic residues 2

Basic residues 1

Polar residues 3

Molecular weight (Average) 1622.82

Molecular weight (Monoisotopic) 1621.7

Common amino acids W

Net charge -1

Instability index (II) 16.38

Aliphatic index 65.00

Grand average of hydropathicity (GRAVY) -0.492

Half Life
2.8 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).

Extinction coefficients
Ext. coefficient 17990
Abs 0.1% (=1 g/l) 11.086

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID US 2011/0319336 A1

Patent Title Selective anticancer chimeric peptide.

Other Iinformation Granted Patent Family: 19s / 19ex; Family Jurisdictions: US, JP, EP, WO, CN; Legal Status: Active; Application No: 200913132580; Filed: Dec 3, 2009; Published: Dec 29, 2011; Earliest Priority: Dec 3, 2008; Granted: May 7, 2013

Other Published ID CN102238965A EP2370107A2 WO2010064207A2 WO2010064207A3